THC241220P155000
- 12.93
- +0.43+3.44%
Tenet Healthcare Newsroom
Tenet Healthcare Cut to Equal-Weight From Overweight by Wells Fargo
Wells Fargo Downgrades Tenet Healthcare(THC.US) to Hold Rating, Cuts Target Price to $150
Tenet Healthcare Analyst Ratings
Raymond James Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $195
Jefferies Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $200
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $190
Barclays Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Tenet Healthcare Is Maintained at Overweight by Wells Fargo
Tenet Healthcare Analyst Ratings
Wells Fargo Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $205
A Quick Look at Today's Ratings for Tenet Healthcare(THC.US), With a Forecast Between $183 to $217
Tenet Healthcare Is Maintained at Outperform by RBC Capital
Tenet Healthcare Analyst Ratings
UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $217
A Quick Look at Today's Ratings for Tenet Healthcare(THC.US), With a Forecast Between $183 to $217
Tenet Healthcare Is Maintained at Overweight by Wells Fargo
Tenet Healthcare Analyst Ratings
Wells Fargo Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $195
Wells Fargo Sticks to Their Buy Rating for Tenet Healthcare (THC)
Tenet Healthcare Is Maintained at Buy by Truist Securities